BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7082647)

  • 21. Estrogen receptor activation and the dissociation kinetics of estradiol, estriol, and estrone.
    Weichman BM; Notides AC
    Endocrinology; 1980 Feb; 106(2):434-9. PubMed ID: 7353517
    [No Abstract]   [Full Text] [Related]  

  • 22. The amino-terminal sequence of the 85-90K nonhormone binding component of the molybdate-stabilized estradiol receptor from calf uterus.
    Ratajczak T; Comber M; Moir R; Hähnel R; Grego B; Rubira MR; Simpson RJ
    Biochem Biophys Res Commun; 1987 Feb; 143(1):218-24. PubMed ID: 3827917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Binding of estrogen receptor to uterine nuclei. Salt-extractable versus salt-resistant receptor-estrogen complexes.
    Traish AM; Müller RE; Wotiz HH
    J Biol Chem; 1977 Oct; 252(19):6823-30. PubMed ID: 893443
    [No Abstract]   [Full Text] [Related]  

  • 24. Characterization of the effect of sodium molybdate and diisopropylfluorophosphate on the human myometrial estrogen and progesterone receptors.
    Lukola A; Punnonen R
    J Steroid Biochem; 1983 Mar; 18(3):231-5. PubMed ID: 6827828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of aging on the dissociation kinetics and estradiol receptor nuclear interactions in mouse uteri: correlation with biological effects.
    Belisle S; Bellabarba D; Lehoux JG; Robel P; Baulieu EE
    Endocrinology; 1986 Feb; 118(2):750-8. PubMed ID: 3943490
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of estrogen receptor activation by its [3H]estradiol dissociation kinetics.
    Weichman BM; Notides AC
    Biochemistry; 1979 Jan; 18(1):220-5. PubMed ID: 420773
    [No Abstract]   [Full Text] [Related]  

  • 27. Human breast tumor estrogen receptor: effects of molybdate and electrophoretic analyses.
    Miller LK; Tuazon FB; Niu EM; Sherman MR
    Endocrinology; 1981 Apr; 108(4):1369-78. PubMed ID: 7472273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transformation of the 8-9 S molybdate-stabilized estrogen receptor from low-affinity to high-affinity state without dissociation into subunits.
    Redeuilh G; Secco C; Mester J; Baulieu EE
    J Biol Chem; 1987 Apr; 262(12):5530-5. PubMed ID: 3571221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation of calf uterus 17 beta-estradiol receptor by endogenous Ca2+-stimulated kinase activating the hormone binding of the receptor.
    Migliaccio A; Lastoria S; Moncharmont B; Rotondi A; Auricchio F
    Biochem Biophys Res Commun; 1982 Dec; 109(3):1002-10. PubMed ID: 6297480
    [No Abstract]   [Full Text] [Related]  

  • 30. Differentiation of estradiol receptors in rat uterine cytosol by sensitivity to tamoxifen.
    Fishman JH; Fishman J
    Biochem Biophys Res Commun; 1979 Mar; 87(2):550-8. PubMed ID: 444239
    [No Abstract]   [Full Text] [Related]  

  • 31. Extensive in situ activation of nuclear estrogen receptors after exposure of murine uteri to [3H]estradiol or [3H]4-hydroxytamoxifen.
    Pavlik EJ; Nelson K; van Nagell JR; Donaldson ES; Walden ML; Gallion H; Kenady DE
    Endocrinology; 1987 Apr; 120(4):1608-14. PubMed ID: 3830064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reversibility of the stabilization effect of sodium molybdate on uterine estrogen and progesterone receptors of the vervet monkey.
    Klein T; Potgieter HC; Spies JH; van der Watt JJ; Savage N
    J Recept Res; 1985; 5(4):267-95. PubMed ID: 4057178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of chlorpromazine on the inhibition and artifactual elevation of [3H]estradiol binding to estrogen receptors in rat uterine cytosol.
    Campbell PS; Clark JH
    J Steroid Biochem; 1984 Oct; 21(4):475-6. PubMed ID: 6387281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of monoclonal antibodies to the nuclear estrogen receptor in intact nuclei.
    Moncharmont B; Parikh I
    Biochem Biophys Res Commun; 1983 Jul; 114(1):107-12. PubMed ID: 6882416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estradiol-binding kinetics of the activated and nonactivated estrogen receptor.
    Weichman BM; Notides AC
    J Biol Chem; 1977 Dec; 252(24):8856-62. PubMed ID: 925028
    [No Abstract]   [Full Text] [Related]  

  • 36. Specific regulation of male rat liver cytosolic estrogen receptor by the modulator of the glucocorticoid receptor.
    Celiker MY; Haas A; Saunders D; Litwack G
    Biochem Biophys Res Commun; 1993 Aug; 195(1):151-7. PubMed ID: 8363596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation kinetics of the estrogen receptor immobilized by hydroxylapatite.
    de Boer W; Notides AC
    Biochemistry; 1981 Mar; 20(5):1285-9. PubMed ID: 7225327
    [No Abstract]   [Full Text] [Related]  

  • 38. Estrogen-binding properties of cytoplasmic and nuclear estrogen receptors in the presence of Triton X-100.
    Pavlik EJ; Rutledge S
    J Steroid Biochem; 1980 Dec; 13(12):1433-41. PubMed ID: 7464123
    [No Abstract]   [Full Text] [Related]  

  • 39. The effects of antioestrogens on the oestrogen receptor.
    Ruh TS; Baudendistel LJ; Nicholson WF; Ruh MF
    J Steroid Biochem; 1979 Jul; 11(1A):315-22. PubMed ID: 491601
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of pyridoxal 5'-phosphate on uterine estrogen receptor. I. Inhibition of nuclear binding in cell-free system and intact uterus.
    Müller RE; Traish A; Wotiz HH
    J Biol Chem; 1980 May; 255(9):4062-7. PubMed ID: 7372666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.